Synopsis of recent research by authors named "Nami Tateyama"
Nami Tateyama's recent research focuses on the development and characterization of monoclonal antibodies targeting various chemokine receptors, such as CCR3, CCR6, CCR9, and CCR2, which play roles in immune responses and cancer progression.
The studies highlight the significance of these receptors in conditions like colorectal cancer and autoimmune diseases, aiming to establish potential therapeutic approaches for treatment through targeted antibody development.
Additionally, Tateyama's work includes innovative epitope mapping techniques for better understanding of antibody interactions and receptor functionalities, which may enhance diagnostic and therapeutic applications in immunology and oncology.